21 results
8-K
EX-2.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
or decree of any Governmental Entity.
(nn) “Key Supplier” means Recipharm HC Limited.
(oo) The “Knowledge” of any Person means, in the case of Parent … and expenses payable to the Key Supplier or otherwise incurred by the Company or any Company Subsidiary in connection with preserving the ability of the Key
8-K
EX-10.1
cspgdcztllw3j5xtcn
1 Mar 21
Satsuma Pharmaceuticals Announces Updated STS101 Development Plan
12:00am
10-K
5izinng
10 Mar 20
Annual report
4:20pm
10-Q
2tz2djy1vmowudlpdw
12 Nov 19
Quarterly report
4:31pm
424B4
0e5cjulxtvs ry
13 Sep 19
Prospectus supplement with pricing info
5:08pm
S-1/A
zd4k7nb9kyul
3 Sep 19
IPO registration (amended)
6:12am
S-1
kxivp 9agfcgw9ai
16 Aug 19
IPO registration
5:15pm
DRS/A
s4vh3o5e q3k8eu
2 Aug 19
Draft registration statement (amended)
12:00am